The U.S. Food & Drug Administration (FDA) regulator has given more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.


30


Reuters

Latest News

NewYorkTimes: Justice Dept. Says It Will Share Some Mueller-Related Intelligence With House Committee

NewYorkTimes: Boeing Faces Compensation Demand From China’s Biggest Airlines

NewYorkTimes: Mnuchin Dismisses I.R.S. Memo Saying Treasury Must Release Trump Tax Returns

CNN: Queen learns how to use self-service checkout

CBC: Japan urges world to put family names first for Japanese

BBC: Stolen Cardiff Castle stones for sale on eBay

ABC: Sorting out recycling programs: Which ones work best?

ABC: 1990s drama 'Party of Five' reboot involves deported parents

WashingtonPost: Reuben Foster injury is painful for Redskins, who viewed him as a potential team leader

FOX: Apple's Siri and Amazon's Alexa spread sexism, UN study reveals: 'I'd blush if I could'

FOX: Anti-groping smartphone app highly popular in Japan

FOX: Assistant Attorney General Williams: Violent crime is declining -- DOJ is working to make America even safer

FOX: Sleeping babies at risk of dying in car seats when used incorrectly, doctors warn

FOX: North Carolina sisters selling lemonade to pay off school district's $41G lunch debt

FOX: Jennifer Garner gives Ohio grads 8 life tips during sassy commencement speech

CBS: Rising sea levels could displace millions in 2 generations

CBC: Just for Laughs adds Wanda Sykes, Nick Kroll, Fred Armisen to 2019 lineup

BBC: Natasha Carruthers death: 'Failed drug deal behind car chase'

BBC: US lawmaker 'punched wife for not undressing quick enough'

ABC: Harris, Gillibrand offer plans to bolster maternal care

ABC: Saudi Aramco to buy liquid natural gas from US company

WashingtonPost: Conor McGregor says ‘war is not over’ with Khabib Nurmagomedov, calls for rematch

WashingtonPost: Reuben Foster injury is painful for Redskins, who viewed him as a potential team leader

13 Related Articles, between 2018-11-05 and 2018-11-02